0001127602-21-028142.txt : 20211102 0001127602-21-028142.hdr.sgml : 20211102 20211102165941 ACCESSION NUMBER: 0001127602-21-028142 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211101 FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ridha Essra CENTRAL INDEX KEY: 0001888732 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38537 FILM NUMBER: 211372264 MAIL ADDRESS: STREET 1: C/O AVROBIO, INC. STREET 2: ONE KENDALL SQUARE, BLDG 300 - SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVROBIO, Inc. CENTRAL INDEX KEY: 0001681087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 810710585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 300, SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7819626030 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 300, SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AvroBio, Inc. DATE OF NAME CHANGE: 20160729 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-11-01 0001681087 AVROBIO, Inc. AVRO 0001888732 Ridha Essra C/O AVROBIO, INC. ONE KENDALL SQUARE, BLD. 300 - SUITE 201 CAMBRIDGE MA 02139 1 Chief Medical Officer Stock Option (Right to Buy) 5.67 2021-11-01 4 A 0 120000 0 A 2031-10-31 Common Stock 120000 120000 D 25% of the shares shall vest and become exercisable on November 1, 2022, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period. /s/ Christopher Gerry, Attorney in Fact for Essra Ridha 2021-11-02